<DOC>
	<DOC>NCT00645372</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy and safety of ziprasidone and risperidone for the treatment of schizophrenia in Chinese patients</brief_summary>
	<brief_title>A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Hospitalized patients with schizophrenia Miminum PANSS score of 60 when randomized Planned, regular use of antipsyhotics within 1 week of randomization Previous treatment with risperidone that resulted in intolerance or lack of response to risperidone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>